Your browser doesn't support javascript.
loading
Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects.
Li, Na; Zethoven, Magnus; McInerny, Simone; Devereux, Lisa; Huang, Yu-Kuan; Thio, Niko; Cheasley, Dane; Gutiérrez-Enríquez, Sara; Moles-Fernández, Alejandro; Diez, Orland; Nguyen-Dumont, Tu; Southey, Melissa C; Hopper, John L; Simard, Jacques; Dumont, Martine; Soucy, Penny; Meindl, Alfons; Schmutzler, Rita; Schmidt, Marjanka K; Adank, Muriel A; Andrulis, Irene L; Hahnen, Eric; Engel, Christoph; Lesueur, Fabienne; Girard, Elodie; Neuhausen, Susan L; Ziv, Elad; Allen, Jamie; Easton, Douglas F; Scott, Rodney J; Gorringe, Kylie L; James, Paul A; Campbell, Ian G.
Afiliação
  • Li N; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.
  • Zethoven M; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic, Australia.
  • McInerny S; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Vic, Australia.
  • Devereux L; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.
  • Huang YK; Bioinformatics Core Facility, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.
  • Thio N; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Vic, Australia.
  • Cheasley D; Lifepool, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.
  • Gutiérrez-Enríquez S; Upper Gastrointestinal Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.
  • Moles-Fernández A; Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Melbourne, Vic, Australia.
  • Diez O; Bioinformatics Core Facility, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.
  • Nguyen-Dumont T; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.
  • Southey MC; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic, Australia.
  • Hopper JL; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO); Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Simard J; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO); Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Dumont M; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO); Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Soucy P; Area of Clinical and Molecular Genetics, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Meindl A; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
  • Schmutzler R; Department of Clinical Pathology, University of Melbourne, Melbourne, Victoria, Australia.
  • Schmidt MK; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
  • Adank MA; Department of Clinical Pathology, University of Melbourne, Melbourne, Victoria, Australia.
  • Andrulis IL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Hahnen E; Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Quebec, Canada.
  • Engel C; Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Quebec, Canada.
  • Lesueur F; Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Quebec, Canada.
  • Girard E; University of Munich, Campus Großhadern, Department of Gynecology and Obstetrics, Munich, Germany.
  • Neuhausen SL; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Familial Breast and Ovarian Cancer, Cologne, Germany.
  • Ziv E; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Integrated Oncology (CIO), Cologne, Germany.
  • Allen J; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
  • Easton DF; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Scott RJ; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Gorringe KL; Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • James PA; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
  • Campbell IG; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
NPJ Breast Cancer ; 7(1): 52, 2021 May 12.
Article em En | MEDLINE | ID: mdl-33980861
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália